Related references
Note: Only part of the references are listed.A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII
Scot A. Fahs et al.
BLOOD (2014)
Murine coagulation factor VIII is synthesized in endothelial cells
Lesley A. Everett et al.
BLOOD (2014)
A novel F8-/- rat as a translational model of human hemophilia A
L. N. Nielsen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Organizing Principles of Mammalian Nonsense-Mediated mRNA Decay
Maximilian Wei-Lin Popp et al.
ANNUAL REVIEW OF GENETICS, VOL 47 (2013)
The diversity of the immune response to the A2 domain of human factor VIII
Rebecca C. Markovitz et al.
BLOOD (2013)
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Corien L. Eckhardt et al.
BLOOD (2013)
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A
Gouri Shankar Pandey et al.
NATURE MEDICINE (2013)
A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains
Michelle M. Simon et al.
GENOME BIOLOGY (2013)
A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function
Shannon L. Meeks et al.
BLOOD (2012)
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Samantha C. Gouw et al.
BLOOD (2012)
Porcine Model of Hemophilia A
Yuji Kashiwakura et al.
PLOS ONE (2012)
Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice
M. Qadura et al.
HAEMOPHILIA (2011)
The spectrum of haemostatic characteristics of women with unexplained menorrhagia
C. H. Miller et al.
HAEMOPHILIA (2011)
WAG-F8m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A
C. J. Booth et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A
C. D. Porada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Factor VIII Inhibitors: Risk Factors and Methods for Prevention and Immune Modulation
Ai Hong Zhang et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2009)
Genetic Differences among C57BL/6 Substrains
Kazuyuki Mekada et al.
EXPERIMENTAL ANIMALS (2009)
Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model
S. L. Meeks et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
A. Pavlova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice
P. C. Ter Avest et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Antihuman factor VIIIC2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation
Shannon L. Meeks et al.
BLOOD (2007)
The humoral response to human factor VIII in hemophilia A mice
J. F. Healey et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation
Peter W. Collins et al.
BLOOD (2007)
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
Birgit M. Reipert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII
R. T. Barrow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains
FEM Rawle et al.
JOURNAL OF GENE MEDICINE (2004)
The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion
JN Lozier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Partial correction of murine hemophilia A with neo-antigenic murine factor VIII
R Sarkar et al.
HUMAN GENE THERAPY (2000)
Correlation between factor VIII genotype and inhibitor development in hemophilia A
SS Fakharzadeh et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)